Schrödinger is transforming the way therapeutics and materials are discovered.
For over 30 years, Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Our multidisciplinary drug discovery team also leverages the software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.
More From Schrödinger
We want to hear from you. Reach out with ideas, questions, and suggestions.
"(Required)" indicates required fields